Skip to main content
Signal8

Adhera Therapeutics Inc (ATRX)

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Sector: Biotechnology

Industry: Biotechnology

Adhera Therapeutics Inc logo

Adhera Therapeutics Inc

OTC:ATRXHealthcare
CLOSED
Mkt Cap-
EV-
Float6.7M
O/S7.22M
VOL20K sh
$ Vol$2
Inst Own-
Net Cash/Sh-
Dilution
Short interest (FINRA)
Not computed yet: no FINRA short interest has been matched to this float.

Float 6.70M · FMP free float

110
Mar 15 (977d)prev 2.0K▼ 94.5%
1.00
Mar 15 (977d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow ATRX shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver

No price or settlement history available to chart.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for ATRX: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually